Jerry Conway holds a Bachelor's degree in Landscape Architecture from Rutgers University and has extensive experience in market access roles within the healthcare and diagnostics industry. Currently serving as the Senior Vice President of Market Access at Belay Diagnostics since April 2024, Conway is focused on advancing proprietary molecular testing technology for brain and spinal cord tumors. Previous positions include Senior Vice President of Market Access at GeneDx, where Conway contributed to delivering personalized health insights, and at Scipher Medicine, where collaboration with physicians and payers was key to developing diagnostic tools for complex diseases. Earlier roles include Executive Vice President at CDx Diagnostics and Vice President of Reimbursement & Payer Strategy at Foundation Medicine, Inc.
This person is not in any teams
This person is not in any offices